UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048611
Receipt number R000055333
Scientific Title Analysis of gene mutations and clinical response and mechanisms of leukemogenesis in acute leukemia
Date of disclosure of the study information 2022/08/08
Last modified on 2024/02/06 10:46:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of gene mutations and clinical response and mechanisms of leukemogenesis in acute leukemia

Acronym

Hokkaido Leukemia Net

Scientific Title

Analysis of gene mutations and clinical response and mechanisms of leukemogenesis in acute leukemia

Scientific Title:Acronym

Hokkaido Leukemia Net

Region

Japan


Condition

Condition

acute leukemia

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

Relationship of genomic alteration and prognosis of acute leukemia is analyzed in Japanese prospective real-world cohort study.

Basic objectives2

Others

Basic objectives -Others

Evaluation of efficacy of international or domestic prognostic classification

Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Overall survival

Key secondary outcomes

Relapse free survival


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) a patient clinically suspected acute leukemia
2) age equal or more than 16
3) a patient who agree to preserve specimen
4) a patient who agree to register this trial

Key exclusion criteria

1) a patient whose leukemic genome DNA or cDNA is not available
2) a patient who is considered as inappropriate to register this trial

Target sample size

1500


Research contact person

Name of lead principal investigator

1st name Masahiro
Middle name
Last name Onozawa

Organization

Hokkaido University Hospital

Division name

Department of Hematology

Zip code

0608638

Address

Kita 15, Nishi 7, Kita-ku, Sapporo

TEL

+81-11-706-7214

Email

onozawa@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Masahiro
Middle name
Last name Onozawa

Organization

Hokkaido University Hospital

Division name

Department of Hematology

Zip code

0608638

Address

Kita 15, Nishi 7, Kita-ku, Sapporo

TEL

+81-11-706-7214

Homepage URL


Email

onozawa@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University Hospital
Department of Hematology

Institute

Department

Personal name



Funding Source

Organization

Hokkaido University Hospital
Department of Hematology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University Hospital

Address

Kita 14, Nishi 5, Kita-ku, Sapporo

Tel

+81-11-706-7061

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道大学病院(北海道)
旭川医科大学(北海道)
札幌医科大学附属病院(北海道)
岩手医科大学附属病院(岩手県)
札幌北楡病院(北海道)
愛育病院(北海道)
市立札幌病院(北海道)
北海道勤労者医療協会勤医協中央病院(北海道)
JA北海道厚生連札幌厚生病院(北海道)
手稲渓仁会病院(北海道)
天使病院(北海道)
KKR札幌医療センター斗南病院(北海道)
国立病院機構北海道がんセンター(北海道)
市立旭川病院(北海道)
JA北海道厚生連帯広厚生病院(北海道)
独立行政法人労働者健康安全機構釧路ろうさい病院(北海道)
北見赤十字病院(北海道)
市立函館病院(北海道)
旭川厚生病院(北海道)
市立根室病院(北海道)
製鉄記念室蘭病院(北海道)
札幌徳洲会病院(北海道)
福島県立医科大学附属病院(福島県)
福島県立医科大学会津医療センター(福島県)


Other administrative information

Date of disclosure of the study information

2022 Year 08 Month 08 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications

https://pubmed.ncbi.nlm.nih.gov/36572814/

Number of participants that the trial has enrolled


Results

Clinical features of complex karyotype in newly diagnosed acute myeloid leukemia

Results date posted

2023 Year 02 Month 05 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2015 Year 11 Month 13 Day

Date of IRB

2016 Year 02 Month 29 Day

Anticipated trial start date

2016 Year 04 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Genetic analysis
AML: FLT3, NPM1, CEBPA, KIT mutation, others
ALL: IKZF1 deletion, others


Management information

Registered date

2022 Year 08 Month 06 Day

Last modified on

2024 Year 02 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055333


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name